RET and neoplasm: Germline mutations that activate RET activity have been associated with multiple endocrine neoplasia 2 (MEN 2), which consists of three primary tumor types (medullary thyroid cancer, pheochromocytoma, and parathyroid hyperplasia or adenoma) [14].